USFDA and DCA Discuss Pharma Quality in Andhra Pradesh

Officials from the USFDA India Office and India's Drug Control Administration recently discussed methods to enhance pharmaceutical manufacturing and drug quality in Andhra Pradesh.

Reported by The Hindu

By AUZZ Newsdesk (The Hindu)

Published Friday 7 August 2026 at 3:00 pm AEST 2 min read

Save article

Language

USFDA and DCA Discuss Pharma Quality in Andhra Pradesh

Listen

0:000:00

Comments (0)

Be the first to comment.

Related coverage

Culture

Sarnath designated as India's 45th UNESCO World Heritage Site

Sarnath, a significant historical site, has reportedly been named as India's 45th UNESCO World Heritage Site.

AUZZ Newsdesk (The Hindu) · 7 min ago

Politics

Opposition Demands FCRA Bill Scrapped or Referred to JPC

According to The Hindu, the INDIA bloc has stated the FCRA Bill targets NGOs and minorities, with Congress linking discussions to a statement on student protesters.

AUZZ Newsdesk (The Hindu) · 7 min ago

World

SCCL to Explore Gold, Copper Deposits in Karnataka

According to The Hindu, SCCL has signed an agreement to explore for gold and copper deposits in Karnataka.

AUZZ Newsdesk (The Hindu) · 7 min ago

USFDA and DCA Discuss Pharma Quality in Andhra Pradesh

Comments (0)

Sarnath designated as India's 45th UNESCO World Heritage Site

Opposition Demands FCRA Bill Scrapped or Referred to JPC

SCCL to Explore Gold, Copper Deposits in Karnataka

Telangana cabbie and gig worker strike called off after talks

Spain Warns Italy Over Border Checks Amid Ceuta Spat

Trilateral Defence Pact Signed by Saudi Arabia, Turkiye, and Pakistan